A multi-centre, randomised, placebo controlled, double blind, parallel group study in female patients to evaluate whether tolterodine ER [extended release] can reverse the increased bladder wall thickness in patients with overactive bladder
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2005
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 19 Nov 2005 New trial record.